Identification of risk factors associated with acute kidney injury in patients admitted to acute medical units

Autor: A Banerjee, JM Atkinson, CT Hunter-Rowe, Andrew Lewington, Benjamin Bray, S Finlay, MC Jones

Publikováno v: Clinical medicine (London, England). 13(3)

In 2009, the National Confidential Enquiry into Patient Outcome and Death (NCEPOD) report identified significant deficiencies in the management of acute kidney injury (AKI) in hospitals in the UK. Many errors arose from failure to recognise patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54fe581da890eb39d353bdb5200afdcf
https://pubmed.ncbi.nlm.nih.gov/23760694

Systemic and local chronic inflammation and hormone disposition promote a tumor-permissive environment for breast cancer in older women.

Autor: Carleton N, Lee S, Li R, Zou J, Brown DD, Hooda J, Chang A, Kumar R, Klei LR, Rigatti LH, Newsome J, John Mary DJS, Atkinson JM, West RE, Nolin TD, Oberly PJ, Huang Z, Poirier D, Diego EJ, Lucas PC, Tseng G, Lotze MT, McAuliffe PF, Zervantonakis IK, Oesterreich S, Lee AV

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Oct 21. Date of Electronic Publication: 2024 Oct 21.

Spatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutations.

Autor: Shah OS; Womens Cancer Research Center at University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center and Magee Women's Research Institute, Pittsburgh, PA 15213.; Integrative Systems Biology Program, University of Pittsburgh School of Medicine, Pittsburgh PA 15260., Nasrazadani A; Womens Cancer Research Center at University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center and Magee Women's Research Institute, Pittsburgh, PA 15213.; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213., Foldi J; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15260., Atkinson JM; Womens Cancer Research Center at University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center and Magee Women's Research Institute, Pittsburgh, PA 15213.; Department of Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, PA 15260., Kleer CG; Department of Pathology and Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109., McAuliffe PF; Womens Cancer Research Center at University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center and Magee Women's Research Institute, Pittsburgh, PA 15213.; Division of Surgical Oncology, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15232., Johnston TJ; Department of Computational and Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213., Stallaert W; Department of Computational and Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213., da Silva EM; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Selenica P; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Dopeso H; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Pareja F; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Mandelker D; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Weigelt B; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Reis-Filho JS; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Bhargava R; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213., Lucas PC; Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine and Science, Rochester, MN 55902., Lee AV; Womens Cancer Research Center at University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center and Magee Women's Research Institute, Pittsburgh, PA 15213.; Department of Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, PA 15260., Oesterreich S; Womens Cancer Research Center at University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center and Magee Women's Research Institute, Pittsburgh, PA 15213.; Department of Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, PA 15260.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2024 Jul 30; Vol. 121 (31), pp. e2322068121. Date of Electronic Publication: 2024 Jul 23.

Research autopsy programmes in oncology: shared experience from 14 centres across the world.

Autor: Geukens T; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium., Maetens M; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium., Hooper JE; Stanford University School of Medicine, Palo Alto, CA, USA., Oesterreich S; University of Pittsburgh UPMC Hillman Cancer Center, and Magee Womens Research Institute, Pittsburgh, PA, USA., Lee AV; University of Pittsburgh UPMC Hillman Cancer Center, and Magee Womens Research Institute, Pittsburgh, PA, USA., Miller L; University of Pittsburgh UPMC Hillman Cancer Center, and Magee Womens Research Institute, Pittsburgh, PA, USA., Atkinson JM; University of Pittsburgh UPMC Hillman Cancer Center, and Magee Womens Research Institute, Pittsburgh, PA, USA., Rosenzweig M; University of Pittsburgh UPMC Hillman Cancer Center, and Magee Womens Research Institute, Pittsburgh, PA, USA., Puhalla S; University of Pittsburgh UPMC Hillman Cancer Center, and Magee Womens Research Institute, Pittsburgh, PA, USA., Thorne H; Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Devereux L; Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Bowtell D; Peter MacCallum Cancer Centre, Melbourne, Australia., Loi S; Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Bacon ER; Center for Precision Medicine, City of Hope National Medical Center, Duarte, CA, USA., Ihle K; Center for Precision Medicine, City of Hope National Medical Center, Duarte, CA, USA., Song M; Center for Precision Medicine, City of Hope National Medical Center, Duarte, CA, USA., Rodriguez-Rodriguez L; Center for Precision Medicine, City of Hope National Medical Center, Duarte, CA, USA., Welm AL; University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA., Gauchay L; University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA., Murali R; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chanda P; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Karacay A; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Naceur-Lombardelli C; UCL Cancer Institute, University College London, London, UK., Bridger H; Cancer Research UK, and UCL Cancer Trials Centre, University College London, London, UK., Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.; Department of Medical Oncology, University College London Hospitals, London, UK., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.; Department of Medical Oncology, University College London Hospitals, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK., Kollath L; University of Washington, Seattle, WA, USA., True L; University of Washington, Seattle, WA, USA., Morrissey C; University of Washington, Seattle, WA, USA., Chambers M; University of Washington, Seattle, WA, USA., Chinnaiyan AM; University of Michigan, Ann Arbor, MI, USA., Wilson A; University of Michigan, Ann Arbor, MI, USA., Mehra R; University of Michigan, Ann Arbor, MI, USA., Reichert Z; University of Michigan, Ann Arbor, MI, USA., Carey LA; University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Perou CM; University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Kelly E; University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Maeda D; Department of Molecular and Cellular Pathology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan., Goto A; Department of Cellular and Organ Pathology, Graduate School of Medicine, Akita University, Akita, Japan., Kulka J; Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary., Székely B; Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary.; National Institute of Oncology, Budapest, Hungary., Szasz AM; Division of Oncology, Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary., Tőkés AM; Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary., Van Den Bogaert W; Department of Forensic Medicine, University Hospitals Leuven, Leuven, Belgium., Floris G; Department of Pathology, University Hospitals Leuven, Leuven, Belgium., Desmedt C; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.

Publikováno v: The Journal of pathology [J Pathol] 2024 Jun; Vol. 263 (2), pp. 150-165. Date of Electronic Publication: 2024 Mar 29.

Systems approach for congruence and selection of cancer models towards precision medicine.

Autor: Zou J; Department of Statistics, School of Public Health, Chongqing Medical University, Chongqing, China., Shah O; Women's Cancer Research Center, UPMC Hillman Cancer Center (HCC), Pittsburgh, Pennsylvania, United States of America.; Magee-Womens Research Institute, Pittsburgh, Pennsylvania, United States of America.; Department of Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America., Chiu YC; Cancer Therapeutics Program, UPMC Hillman Cancer Center (HCC), Pittsburgh, Pennsylvania, United States of America.; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America., Ma T; Department of Epidemiology and Biostatistics, University of Maryland, College Park, Maryland, United States of America., Atkinson JM; Women's Cancer Research Center, UPMC Hillman Cancer Center (HCC), Pittsburgh, Pennsylvania, United States of America.; Magee-Womens Research Institute, Pittsburgh, Pennsylvania, United States of America.; Department of Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America., Oesterreich S; Women's Cancer Research Center, UPMC Hillman Cancer Center (HCC), Pittsburgh, Pennsylvania, United States of America.; Magee-Womens Research Institute, Pittsburgh, Pennsylvania, United States of America.; Department of Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America., Lee AV; Women's Cancer Research Center, UPMC Hillman Cancer Center (HCC), Pittsburgh, Pennsylvania, United States of America.; Magee-Womens Research Institute, Pittsburgh, Pennsylvania, United States of America.; Department of Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America., Tseng GC; Department of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.

Publikováno v: PLoS computational biology [PLoS Comput Biol] 2024 Jan 10; Vol. 20 (1), pp. e1011754. Date of Electronic Publication: 2024 Jan 10 (Print Publication: 2024).